Board Meetings for AJANTPHARM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| AJANTPHARM | Ajanta Pharma Limited | 27 Jul 2023 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 | |
| AJANTPHARM | Ajanta Pharma Limited | 05 May 2023 | Financial Results | To consider and approve the financial results for the period ended March 31, 2023 | |
| AJANTPHARM | Ajanta Pharma Limited | 05 May 2023 | AJANTA PHARMA LIMITEDhas informed the Exchange about Board Meeting to be held on 05-May-2023to inter-alia consider and approve the Audited financial results of the Company for the Yearly ended March 2023 . | Board Meeting Intimation | |
| AJANTPHARM | Ajanta Pharma Limited | 10 Mar 2023 | Buyback | To consider buyback for equity shares | |
| AJANTPHARM | Ajanta Pharma Limited | 01 Feb 2023 | Financial Results | To consider and approve the financial results for the period ended December 31, 2022 | |
| AJANTPHARM | Ajanta Pharma Limited | 03 Nov 2022 | Dividend | This is with reference to our letter dated 21st October 2022, informing you about the Board meeting scheduled on Thursday, 3rd November 2022 to inter-alia consider and take on record the unaudited financial results for the second quarter and half year ended 30th September 2022.Pursuant to Regulation 29(1)(e) of Listing Regulations, we hereby inform you that, at the aforesaid Board Meeting, the Board of Directors will also consider proposal for:a. declaration of interim dividend, if any, for the financial year ending 31st March 2023; andb. fixation of Monday, 14th November, 2022 as the Record Date for the payment of interim dividend, if declared.You are requested to please take a note of the same and disseminate to all concerned. | |
| AJANTPHARM | Ajanta Pharma Limited | 03 Nov 2022 | Financial results | Ajanta Pharma Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2022 to consider financial statements for the period ended September 2022 | |
| AJANTPHARM | Ajanta Pharma Limited | 28 Jul 2022 | Financial results | Ajanta Pharma Limited has informed the Exchange about Board Meeting to be held on 28-Jul-2022 to consider financial statements for the period ended June 2022 | |
| AJANTPHARM | Ajanta Pharma Limited | 10 May 2022 | Bonus/Financial results | Ajanta Pharma Limited has informed the Exchange about Board Meeting to be held on 10-May-2022 to consider financial statements for the period ended March 2022 and Bonus | |
| AJANTPHARM | Ajanta Pharma Limited | 31 Jan 2022 | Financial Results | To consider and approve the financial results for the period ended December 31, 2021 | |
| AJANTPHARM | Ajanta Pharma Limited | 28 Dec 2021 | Buyback | To consider buyback for equity shares | |
| AJANTPHARM | Ajanta Pharma Limited | 29 Oct 2021 | Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2021 and dividend | |
| AJANTPHARM | Ajanta Pharma Limited | 29 Jul 2021 | Financial Results | To consider and approve the unaudited consolidated and standalone financial results for the period ended Jun 30, 2021 | |
| AJANTPHARM | Ajanta Pharma Limited | 30 Apr 2021 | Financial Results | To consider and approve the financial results for the period ended March 31, 2021 | |
| AJANTPHARM | Ajanta Pharma Limited | 02 Feb 2021 | Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |